TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Chemoform Scandinavia AB
Closing information (x1000 EUR)
| Closing information | 2024/10 | 2023/10 | 2022/10 |
| Turnover |
6,272
|
6,227
|
9,542 |
| Financial expenses |
95
|
387
|
60 |
| Earnings before taxes |
-169
|
-788
|
893 |
| EBITDA |
-54
|
-385
|
976 |
| Total assets |
3,823
|
3,878
|
4,747 |
| Current assets |
3,774
|
3,830
|
4,670 |
| Current liabilities |
2,496
|
2,406
|
2,295 |
| Equity capital |
1,327
|
1,472
|
2,330 |
| - share capital |
86
|
85
|
92 |
| Employees (average) |
15
|
17
|
14 |
Financial ratios
| Fiscal year | 2024/10 | 2023/10 | 2022/10 |
| Solvency |
34.7%
|
38.0%
|
49.1% |
| Turnover per employee |
418
|
366
|
682 |
| Profit as a percentage of turnover |
-2.7%
|
-12.7%
|
9.4% |
| Return on assets (ROA) |
-1.9%
|
-10.3%
|
20.1% |
| Current ratio |
151.2%
|
159.2%
|
203.5% |
| Return on equity (ROE) |
-12.7%
|
-53.5%
|
38.3% |
| Change turnover |
-58
|
-2,571
|
-1,029 |
| Change turnover % |
-1%
|
-29%
|
-10% |
| Chg. No. of employees |
-2
|
3
|
0 |
| Chg. No. of employees % |
-12%
|
21%
|
0% |
Total value of public sale
| Fiscal year | 2024/10 | 2023/10 | 2022/10 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.